Several scientific studies have shown that abnormal microRNA expression levels varies and creates a unique, specific pattern for each type of cancer, even at the early stages, reflecting the progression of the disease, and whether it's responding to medication or in remission, making microRNAs a perfect, highly sensitive biomarker.
Varios estudos científicos demostraron que uns niveis de expresión de microARN anormais varían e crean un patrón único e concreto para cada tipo de cancro, mesmo nas primeiras fases, reflectindo o avance da doenza e se responde ao tratamento ou se remite, convertendo aos microARN nun biomarcador perfecto e moi sensible.